Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Malignant Mesothelioma|Colorectal Cancer|Bile Duct Cancer|Rectal Cancer|Ovary Cancer|Pancreatic Cancer|Breast Cancer Female
Interventions: BIOLOGICAL: UCMYM802 Injection
Sponsor: UTC Therapeutics Inc.
Collaborators: Peking University Cancer Hospital & Institute